Intrapericardial angiotensin II stimulates endothelin-1 and atrial natriuretic peptide formation of the in situ dog heart

Ildikó Toma, Balázs Sax, Andrea Nagy, L. Entz, M. Rusvai, A. Juhász-Nagy, V. Kékesi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Angiotensin (AT) II, endothelin (ET)-1, and atrial natriuretic peptide (ANP) play an important role in cardiovascular regulatory processes under physiologic and pathophysiologic conditions. All of these agents are present in the pericardial fluid, and alteration of their pericardial concentrations mirror changes in the myocardial interstitium. Moreover, the composition the pericardial fluid may also reflect the myocardial interaction of these agents. The local myocardial effects of AT II on cardiac ET-1 and ANP production, as well as on cardiovascular function, was studied by intrapericardial (ip) administration of AT II (0.125-1.0 μg/kg) to the in situ dog heart (n = 8). Big ET, ET-1, and ANP [1-28] fragment concentrations were measured by enzyme-linked immunosorbent assay in pericardial infusate samples and in peripheral blood before and after an AT II treatment of 15 mins. Systemic blood pressure (BP), heart rate (HR), and left ventricular contractility (dP/dt) were also recorded. In our studies, the pericardial big ET (but not ET-1) concentration was increased to a maximum value of 139 ± 28 versus 74 ± 12 pg/ml (control; P <0.02) with ip AT II administration, with parallel elevations of the pericardial ANP levels (36.8 ± 7.2 vs. 24.4 ± 3.6 ng/ml; P <0.05). The ip administration of AT II did not influence HR, and it elicited moderate changes in BP (BPmax, +14 ± 2 mm Hg, P <0.001; dP/dtmax, +10 ± 3%, P <0.02). The plasma levels of big ET, ET-1, and ANP did not change significantly. The results suggest that AT II promotes production of big ET and ANP in the heart. However, no detectable conversion of big ET-1 to ET-1 was observed within 15 mins. The myocardial formation of big ET-1 and ANP occurred, at least in part, independently of the changes in cardiovascular function.

Original languageEnglish
Pages (from-to)847-851
Number of pages5
JournalExperimental Biology and Medicine
Volume231
Issue number6
Publication statusPublished - Jun 2006

Fingerprint

Atrial Natriuretic Factor
Endothelin-1
Angiotensin II
Dogs
Blood pressure
Heart Rate
Blood Pressure
Immunosorbents
Fluids
Assays
Mirrors
Blood
Enzyme-Linked Immunosorbent Assay
Plasmas

Keywords

  • Angiotensin II
  • Atrial natriuretic peptide
  • Cardiovascular physiology
  • Endothelin-1
  • Pericardium

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Intrapericardial angiotensin II stimulates endothelin-1 and atrial natriuretic peptide formation of the in situ dog heart. / Toma, Ildikó; Sax, Balázs; Nagy, Andrea; Entz, L.; Rusvai, M.; Juhász-Nagy, A.; Kékesi, V.

In: Experimental Biology and Medicine, Vol. 231, No. 6, 06.2006, p. 847-851.

Research output: Contribution to journalArticle

@article{3170eb636cbb475abaccd2e3a405bf46,
title = "Intrapericardial angiotensin II stimulates endothelin-1 and atrial natriuretic peptide formation of the in situ dog heart",
abstract = "Angiotensin (AT) II, endothelin (ET)-1, and atrial natriuretic peptide (ANP) play an important role in cardiovascular regulatory processes under physiologic and pathophysiologic conditions. All of these agents are present in the pericardial fluid, and alteration of their pericardial concentrations mirror changes in the myocardial interstitium. Moreover, the composition the pericardial fluid may also reflect the myocardial interaction of these agents. The local myocardial effects of AT II on cardiac ET-1 and ANP production, as well as on cardiovascular function, was studied by intrapericardial (ip) administration of AT II (0.125-1.0 μg/kg) to the in situ dog heart (n = 8). Big ET, ET-1, and ANP [1-28] fragment concentrations were measured by enzyme-linked immunosorbent assay in pericardial infusate samples and in peripheral blood before and after an AT II treatment of 15 mins. Systemic blood pressure (BP), heart rate (HR), and left ventricular contractility (dP/dt) were also recorded. In our studies, the pericardial big ET (but not ET-1) concentration was increased to a maximum value of 139 ± 28 versus 74 ± 12 pg/ml (control; P <0.02) with ip AT II administration, with parallel elevations of the pericardial ANP levels (36.8 ± 7.2 vs. 24.4 ± 3.6 ng/ml; P <0.05). The ip administration of AT II did not influence HR, and it elicited moderate changes in BP (BPmax, +14 ± 2 mm Hg, P <0.001; dP/dtmax, +10 ± 3{\%}, P <0.02). The plasma levels of big ET, ET-1, and ANP did not change significantly. The results suggest that AT II promotes production of big ET and ANP in the heart. However, no detectable conversion of big ET-1 to ET-1 was observed within 15 mins. The myocardial formation of big ET-1 and ANP occurred, at least in part, independently of the changes in cardiovascular function.",
keywords = "Angiotensin II, Atrial natriuretic peptide, Cardiovascular physiology, Endothelin-1, Pericardium",
author = "Ildik{\'o} Toma and Bal{\'a}zs Sax and Andrea Nagy and L. Entz and M. Rusvai and A. Juh{\'a}sz-Nagy and V. K{\'e}kesi",
year = "2006",
month = "6",
language = "English",
volume = "231",
pages = "847--851",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "1535-3702",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Intrapericardial angiotensin II stimulates endothelin-1 and atrial natriuretic peptide formation of the in situ dog heart

AU - Toma, Ildikó

AU - Sax, Balázs

AU - Nagy, Andrea

AU - Entz, L.

AU - Rusvai, M.

AU - Juhász-Nagy, A.

AU - Kékesi, V.

PY - 2006/6

Y1 - 2006/6

N2 - Angiotensin (AT) II, endothelin (ET)-1, and atrial natriuretic peptide (ANP) play an important role in cardiovascular regulatory processes under physiologic and pathophysiologic conditions. All of these agents are present in the pericardial fluid, and alteration of their pericardial concentrations mirror changes in the myocardial interstitium. Moreover, the composition the pericardial fluid may also reflect the myocardial interaction of these agents. The local myocardial effects of AT II on cardiac ET-1 and ANP production, as well as on cardiovascular function, was studied by intrapericardial (ip) administration of AT II (0.125-1.0 μg/kg) to the in situ dog heart (n = 8). Big ET, ET-1, and ANP [1-28] fragment concentrations were measured by enzyme-linked immunosorbent assay in pericardial infusate samples and in peripheral blood before and after an AT II treatment of 15 mins. Systemic blood pressure (BP), heart rate (HR), and left ventricular contractility (dP/dt) were also recorded. In our studies, the pericardial big ET (but not ET-1) concentration was increased to a maximum value of 139 ± 28 versus 74 ± 12 pg/ml (control; P <0.02) with ip AT II administration, with parallel elevations of the pericardial ANP levels (36.8 ± 7.2 vs. 24.4 ± 3.6 ng/ml; P <0.05). The ip administration of AT II did not influence HR, and it elicited moderate changes in BP (BPmax, +14 ± 2 mm Hg, P <0.001; dP/dtmax, +10 ± 3%, P <0.02). The plasma levels of big ET, ET-1, and ANP did not change significantly. The results suggest that AT II promotes production of big ET and ANP in the heart. However, no detectable conversion of big ET-1 to ET-1 was observed within 15 mins. The myocardial formation of big ET-1 and ANP occurred, at least in part, independently of the changes in cardiovascular function.

AB - Angiotensin (AT) II, endothelin (ET)-1, and atrial natriuretic peptide (ANP) play an important role in cardiovascular regulatory processes under physiologic and pathophysiologic conditions. All of these agents are present in the pericardial fluid, and alteration of their pericardial concentrations mirror changes in the myocardial interstitium. Moreover, the composition the pericardial fluid may also reflect the myocardial interaction of these agents. The local myocardial effects of AT II on cardiac ET-1 and ANP production, as well as on cardiovascular function, was studied by intrapericardial (ip) administration of AT II (0.125-1.0 μg/kg) to the in situ dog heart (n = 8). Big ET, ET-1, and ANP [1-28] fragment concentrations were measured by enzyme-linked immunosorbent assay in pericardial infusate samples and in peripheral blood before and after an AT II treatment of 15 mins. Systemic blood pressure (BP), heart rate (HR), and left ventricular contractility (dP/dt) were also recorded. In our studies, the pericardial big ET (but not ET-1) concentration was increased to a maximum value of 139 ± 28 versus 74 ± 12 pg/ml (control; P <0.02) with ip AT II administration, with parallel elevations of the pericardial ANP levels (36.8 ± 7.2 vs. 24.4 ± 3.6 ng/ml; P <0.05). The ip administration of AT II did not influence HR, and it elicited moderate changes in BP (BPmax, +14 ± 2 mm Hg, P <0.001; dP/dtmax, +10 ± 3%, P <0.02). The plasma levels of big ET, ET-1, and ANP did not change significantly. The results suggest that AT II promotes production of big ET and ANP in the heart. However, no detectable conversion of big ET-1 to ET-1 was observed within 15 mins. The myocardial formation of big ET-1 and ANP occurred, at least in part, independently of the changes in cardiovascular function.

KW - Angiotensin II

KW - Atrial natriuretic peptide

KW - Cardiovascular physiology

KW - Endothelin-1

KW - Pericardium

UR - http://www.scopus.com/inward/record.url?scp=33744898781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744898781&partnerID=8YFLogxK

M3 - Article

VL - 231

SP - 847

EP - 851

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 1535-3702

IS - 6

ER -